Novo Nordisk Ozempic Pen

News

Novo Nordisk shares fall

Novo Nordisk names new CEO amid share price slump and concerns over Wegovy, Ozempic sales

The announcement came amid a slump in the company's share price and investor concerns about its experimental drug pipeline and ability to navigate challenges in the US market.

· 1h

Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

· 7h · on MSN

Novo Nordisk shares fall as it slashes 2025 outlook amid US sales drag

UNILAD1d

Study reveals what happens to your body after you stop taking weight loss drugs

New research has revealed that people taking weight loss drugs like Wegovy and Mounjaro are increasingly more likely to ...

15m

Ozempic maker Novo Nordisk on track for its worst day since Black Monday

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

2mon MSN

The Obesity Bubble Has Finally Burst. Novo Nordisk Shares Drop 21%.

Novo Nordisk stock (ticker: NVO) fell after the drugmaker unexpectedly cuts its full-year guidance, citing lower sales ...

10hon MSN

Weight-loss drug boom likely to fuel an injector pen maker

As weight-loss drug sales surge with semaglutide's patent expiration, Gujarat's Shaily Engineering Plastics, an injector pen ...

Wall Street Journal1y

Novo Nordisk Tops $500 Billion Valuation; Ozempic, Wegovy Fuel Earnings

Ozempic pens being assembled at the Novo Nordisk factory in Hillerod, Denmark. (Charlotte de la Fuente for The Wall Street Journal) Shares of Europe's most valuable company rallied around 3.6% ...

Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO, shares plunge

Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results